We recently reported that OBP-301 enhances the cytotoxic effect of chemotherapeutic agents in human osteosarcoma cells by suppressing MCL1 expression through the activation of a transcription factor E2F1-microRNA pathway, resulting in the induction of apoptosis [17]. The gene discussed is E2F1; the disease is osteosarcoma.